| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Tomography, Optical Coherence | 17 | 2019 | 1008 | 2.38 | Why? |
| Calreticulin | 3 | 2019 | 38 | 2.28 | Why? |
| Choroid | 8 | 2018 | 112 | 2.16 | Why? |
| Choroidal Neovascularization | 6 | 2018 | 96 | 1.94 | Why? |
| STAT3 Transcription Factor | 6 | 2019 | 268 | 1.87 | Why? |
| DNA (Cytosine-5-)-Methyltransferase 1 | 4 | 2018 | 11 | 1.82 | Why? |
| Carboxylic Ester Hydrolases | 3 | 2019 | 16 | 1.70 | Why? |
| Cocaine | 3 | 2019 | 73 | 1.61 | Why? |
| Gene Expression Regulation, Neoplastic | 10 | 2019 | 1014 | 1.60 | Why? |
| Sp1 Transcription Factor | 6 | 2019 | 33 | 1.40 | Why? |
| Retinal Vessels | 5 | 2017 | 255 | 1.36 | Why? |
| Interleukin-33 | 2 | 2018 | 120 | 1.33 | Why? |
| Butyrylcholinesterase | 4 | 2019 | 20 | 1.32 | Why? |
| 3-Phosphoinositide-Dependent Protein Kinases | 4 | 2019 | 4 | 1.28 | Why? |
| Macular Degeneration | 4 | 2018 | 194 | 1.27 | Why? |
| Sesquiterpenes | 4 | 2018 | 77 | 1.22 | Why? |
| HMGB1 Protein | 5 | 2018 | 223 | 1.16 | Why? |
| Insulin-Like Growth Factor Binding Protein 1 | 3 | 2018 | 12 | 1.13 | Why? |
| Synovial Membrane | 3 | 2019 | 72 | 1.11 | Why? |
| DNA Methylation | 3 | 2018 | 688 | 1.11 | Why? |
| RNA, Long Noncoding | 6 | 2019 | 408 | 1.06 | Why? |
| Recombinant Fusion Proteins | 2 | 2019 | 919 | 1.01 | Why? |
| Fluorescein Angiography | 8 | 2018 | 426 | 0.98 | Why? |
| Prostaglandin-E Synthases | 5 | 2020 | 21 | 0.96 | Why? |
| Synoviocytes | 2 | 2019 | 13 | 0.96 | Why? |
| Forkhead Box Protein O3 | 2 | 2018 | 30 | 0.94 | Why? |
| Dendritic Cells | 3 | 2018 | 1330 | 0.89 | Why? |
| Hydrolases | 2 | 2018 | 34 | 0.89 | Why? |
| Arthritis, Rheumatoid | 3 | 2019 | 2043 | 0.86 | Why? |
| Bacterial Proteins | 4 | 2019 | 1318 | 0.85 | Why? |
| Human Umbilical Vein Endothelial Cells | 2 | 2019 | 286 | 0.83 | Why? |
| ELAV-Like Protein 1 | 1 | 2019 | 2 | 0.82 | Why? |
| Biomarkers, Tumor | 3 | 2019 | 1314 | 0.81 | Why? |
| Computed Tomography Angiography | 5 | 2018 | 2153 | 0.81 | Why? |
| Diverticulum | 1 | 2019 | 28 | 0.81 | Why? |
| Tristetraprolin | 1 | 2019 | 4 | 0.80 | Why? |
| Patched-1 Receptor | 1 | 2018 | 4 | 0.79 | Why? |
| Wet Macular Degeneration | 2 | 2018 | 102 | 0.79 | Why? |
| Chromosomal Proteins, Non-Histone | 1 | 2019 | 33 | 0.78 | Why? |
| Protein Phosphatase 2 | 1 | 2018 | 18 | 0.78 | Why? |
| Atractylodes | 1 | 2018 | 2 | 0.78 | Why? |
| Phosphorylation | 11 | 2019 | 1060 | 0.78 | Why? |
| Plant Immunity | 1 | 2018 | 5 | 0.77 | Why? |
| S100 Proteins | 1 | 2018 | 25 | 0.77 | Why? |
| Adenosine Triphosphatases | 1 | 2019 | 78 | 0.76 | Why? |
| Zebrafish Proteins | 1 | 2018 | 37 | 0.76 | Why? |
| Smad2 Protein | 1 | 2018 | 20 | 0.76 | Why? |
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2018 | 45 | 0.76 | Why? |
| Retinal Telangiectasis | 1 | 2018 | 4 | 0.76 | Why? |
| Recombinant Proteins | 6 | 2020 | 3786 | 0.76 | Why? |
| Myeloid Cell Leukemia Sequence 1 Protein | 1 | 2018 | 12 | 0.75 | Why? |
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2018 | 39 | 0.75 | Why? |
| Cell Proliferation | 14 | 2019 | 1973 | 0.75 | Why? |
| bcl-X Protein | 1 | 2018 | 19 | 0.75 | Why? |
| Proto-Oncogene Proteins c-akt | 2 | 2019 | 372 | 0.75 | Why? |
| Phosphatidylinositol 3-Kinase | 1 | 2018 | 28 | 0.74 | Why? |
| Smad3 Protein | 1 | 2018 | 40 | 0.74 | Why? |
| 5-Methylcytosine | 1 | 2018 | 16 | 0.74 | Why? |
| Melanoma, Experimental | 1 | 2018 | 57 | 0.73 | Why? |
| Ciliary Arteries | 1 | 2017 | 5 | 0.73 | Why? |
| beta-Crystallin B Chain | 1 | 2017 | 1 | 0.73 | Why? |
| DNA, Intergenic | 1 | 2017 | 7 | 0.73 | Why? |
| Wnt Signaling Pathway | 1 | 2018 | 87 | 0.72 | Why? |
| Carcinoma, Hepatocellular | 2 | 2019 | 1222 | 0.72 | Why? |
| MicroRNAs | 4 | 2019 | 1787 | 0.72 | Why? |
| Encephalomyelitis | 1 | 2018 | 75 | 0.72 | Why? |
| Locomotion | 1 | 2019 | 130 | 0.72 | Why? |
| Mice, Nude | 11 | 2019 | 340 | 0.72 | Why? |
| Cicatrix | 1 | 2019 | 129 | 0.72 | Why? |
| Interleukin-1 Receptor-Like 1 Protein | 1 | 2018 | 92 | 0.72 | Why? |
| Neuroglia | 1 | 2018 | 130 | 0.71 | Why? |
| B7-H1 Antigen | 2 | 2019 | 541 | 0.71 | Why? |
| Codon, Nonsense | 1 | 2017 | 66 | 0.70 | Why? |
| Intercellular Adhesion Molecule-1 | 1 | 2019 | 189 | 0.70 | Why? |
| Nystagmus, Pathologic | 1 | 2017 | 30 | 0.69 | Why? |
| TRPC Cation Channels | 1 | 2017 | 7 | 0.69 | Why? |
| DNA-Binding Proteins | 2 | 2018 | 469 | 0.69 | Why? |
| Neoplastic Stem Cells | 1 | 2018 | 120 | 0.68 | Why? |
| Heroin Dependence | 1 | 2017 | 37 | 0.68 | Why? |
| Endonucleases | 1 | 2017 | 68 | 0.68 | Why? |
| Cocaine-Related Disorders | 1 | 2017 | 51 | 0.67 | Why? |
| Apoptosis | 7 | 2019 | 2335 | 0.66 | Why? |
| MAP Kinase Signaling System | 2 | 2019 | 360 | 0.66 | Why? |
| CTLA-4 Antigen | 1 | 2018 | 282 | 0.66 | Why? |
| Cancer Vaccines | 1 | 2018 | 136 | 0.66 | Why? |
| Diagnostic Techniques, Ophthalmological | 1 | 2018 | 136 | 0.65 | Why? |
| Berberine | 1 | 2017 | 98 | 0.65 | Why? |
| Cell Line, Tumor | 15 | 2019 | 3608 | 0.64 | Why? |
| Up-Regulation | 4 | 2019 | 2249 | 0.64 | Why? |
| Disease | 1 | 2018 | 126 | 0.64 | Why? |
| Rest | 1 | 2017 | 188 | 0.64 | Why? |
| Liver Neoplasms | 2 | 2019 | 1666 | 0.63 | Why? |
| Phenols | 1 | 2018 | 226 | 0.63 | Why? |
| Glycyrrhizic Acid | 1 | 2018 | 190 | 0.63 | Why? |
| Lymphatic Metastasis | 1 | 2018 | 537 | 0.62 | Why? |
| Trans-Activators | 1 | 2017 | 170 | 0.62 | Why? |
| Nerve Net | 1 | 2017 | 118 | 0.62 | Why? |
| Brain Mapping | 1 | 2017 | 228 | 0.61 | Why? |
| Neoplasm Proteins | 2 | 2018 | 501 | 0.61 | Why? |
| Tumor Necrosis Factor-alpha | 6 | 2019 | 2483 | 0.60 | Why? |
| Signal Transduction | 11 | 2019 | 7207 | 0.60 | Why? |
| Solanaceous Alkaloids | 3 | 2019 | 9 | 0.60 | Why? |
| Collagenases | 1 | 2014 | 26 | 0.58 | Why? |
| Immunoglobulin Fc Fragments | 1 | 2019 | 691 | 0.57 | Why? |
| Tumor Necrosis Factor Receptor Superfamily, Member 7 | 1 | 2014 | 58 | 0.56 | Why? |
| Sarcoma | 1 | 2018 | 290 | 0.56 | Why? |
| Metformin | 4 | 2017 | 640 | 0.55 | Why? |
| Hippocampus | 1 | 2017 | 237 | 0.55 | Why? |
| Myeloid-Derived Suppressor Cells | 1 | 2018 | 316 | 0.55 | Why? |
| Cell Death | 1 | 2017 | 536 | 0.55 | Why? |
| Cataract | 1 | 2017 | 186 | 0.54 | Why? |
| Urologic Neoplasms | 1 | 2018 | 348 | 0.53 | Why? |
| Acinetobacter baumannii | 1 | 2017 | 378 | 0.53 | Why? |
| Drug Overdose | 2 | 2018 | 583 | 0.53 | Why? |
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2019 | 581 | 0.53 | Why? |
| Enhancer of Zeste Homolog 2 Protein | 3 | 2018 | 40 | 0.53 | Why? |
| Coronary Artery Disease | 3 | 2018 | 2570 | 0.52 | Why? |
| Fibroblasts | 1 | 2018 | 839 | 0.52 | Why? |
| Transcription Factors | 1 | 2019 | 784 | 0.50 | Why? |
| Ovarian Neoplasms | 1 | 2018 | 465 | 0.50 | Why? |
| Stomach Neoplasms | 1 | 2018 | 477 | 0.50 | Why? |
| Phenotype | 3 | 2018 | 4037 | 0.49 | Why? |
| Gene Regulatory Networks | 1 | 2018 | 820 | 0.49 | Why? |
| Status Epilepticus | 1 | 2017 | 303 | 0.49 | Why? |
| Inflammasomes | 1 | 2019 | 710 | 0.47 | Why? |
| Macrophages | 3 | 2019 | 2784 | 0.47 | Why? |
| Animals | 43 | 2019 | 78931 | 0.46 | Why? |
| T-Lymphocytes, Regulatory | 1 | 2018 | 698 | 0.46 | Why? |
| Interferons | 3 | 2020 | 2885 | 0.45 | Why? |
| Imaging, Three-Dimensional | 1 | 2016 | 680 | 0.44 | Why? |
| RNA | 1 | 2019 | 1278 | 0.44 | Why? |
| Rats | 7 | 2019 | 2764 | 0.44 | Why? |
| Pancreatic Neoplasms | 1 | 2018 | 609 | 0.43 | Why? |
| Lung Neoplasms | 8 | 2019 | 3228 | 0.43 | Why? |
| Cell Cycle Checkpoints | 7 | 2018 | 126 | 0.42 | Why? |
| Electroencephalography | 1 | 2017 | 1242 | 0.41 | Why? |
| Macula Lutea | 3 | 2018 | 87 | 0.39 | Why? |
| CHO Cells | 4 | 2019 | 831 | 0.38 | Why? |
| Atherosclerosis | 1 | 2017 | 768 | 0.38 | Why? |
| Heart Defects, Congenital | 1 | 2018 | 933 | 0.38 | Why? |
| Cricetulus | 4 | 2019 | 936 | 0.37 | Why? |
| Heroin | 2 | 2018 | 41 | 0.37 | Why? |
| Lymphocytes | 2 | 2018 | 3056 | 0.37 | Why? |
| Heart | 1 | 2018 | 1791 | 0.37 | Why? |
| Cell Movement | 5 | 2019 | 695 | 0.37 | Why? |
| Killer Cells, Natural | 2 | 2018 | 2093 | 0.36 | Why? |
| Mice | 21 | 2019 | 21357 | 0.36 | Why? |
| Genetic Predisposition to Disease | 4 | 2021 | 4027 | 0.35 | Why? |
| Leukocytes, Mononuclear | 1 | 2018 | 2115 | 0.35 | Why? |
| Capillaries | 4 | 2018 | 257 | 0.35 | Why? |
| Lactones | 2 | 2018 | 62 | 0.35 | Why? |
| Choroiditis | 2 | 2018 | 18 | 0.35 | Why? |
| Genome-Wide Association Study | 3 | 2021 | 1648 | 0.34 | Why? |
| Rats, Sprague-Dawley | 3 | 2019 | 987 | 0.34 | Why? |
| Gene Expression Profiling | 1 | 2019 | 3788 | 0.33 | Why? |
| Polymorphism, Single Nucleotide | 3 | 2021 | 3607 | 0.33 | Why? |
| Neoplasm Invasiveness | 3 | 2018 | 582 | 0.33 | Why? |
| Female | 61 | 2020 | 380317 | 0.33 | Why? |
| Base Sequence | 4 | 2019 | 3581 | 0.32 | Why? |
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 2 | 2019 | 54 | 0.32 | Why? |
| AMP-Activated Protein Kinases | 3 | 2017 | 93 | 0.32 | Why? |
| PPAR gamma | 3 | 2017 | 102 | 0.31 | Why? |
| Genomics | 1 | 2018 | 3118 | 0.31 | Why? |
| Disease Models, Animal | 12 | 2019 | 10998 | 0.30 | Why? |
| Monocytes | 1 | 2018 | 2978 | 0.30 | Why? |
| Humans | 95 | 2021 | 930598 | 0.30 | Why? |
| Reperfusion Injury | 2 | 2018 | 178 | 0.30 | Why? |
| Mice, Knockout | 4 | 2018 | 1815 | 0.30 | Why? |
| Foreign-Body Reaction | 1 | 2004 | 8 | 0.30 | Why? |
| Male | 54 | 2020 | 367725 | 0.30 | Why? |
| Colitis | 2 | 2019 | 266 | 0.29 | Why? |
| Fundus Oculi | 7 | 2018 | 237 | 0.29 | Why? |
| Polypropylenes | 1 | 2004 | 121 | 0.29 | Why? |
| Surgical Mesh | 1 | 2004 | 55 | 0.28 | Why? |
| Cytokines | 5 | 2019 | 15010 | 0.28 | Why? |
| Abdominal Wall | 1 | 2004 | 62 | 0.28 | Why? |
| Psoriasis | 1 | 2019 | 1739 | 0.28 | Why? |
| Brain | 4 | 2018 | 5133 | 0.28 | Why? |
| Epilepsy | 1 | 2017 | 1401 | 0.27 | Why? |
| Mice, Inbred C57BL | 7 | 2018 | 5542 | 0.27 | Why? |
| CD8-Positive T-Lymphocytes | 2 | 2018 | 5837 | 0.27 | Why? |
| Xenograft Model Antitumor Assays | 3 | 2019 | 274 | 0.26 | Why? |
| Neurons | 2 | 2017 | 864 | 0.26 | Why? |
| Ventral Tegmental Area | 1 | 2002 | 3 | 0.26 | Why? |
| Opioid Peptides | 1 | 2002 | 10 | 0.25 | Why? |
| Retina | 2 | 2018 | 424 | 0.25 | Why? |
| Enzyme Inhibitors | 3 | 2018 | 1881 | 0.24 | Why? |
| Algorithms | 2 | 2017 | 7346 | 0.24 | Why? |
| Down-Regulation | 2 | 2019 | 1416 | 0.23 | Why? |
| Acetylation | 2 | 2018 | 124 | 0.23 | Why? |
| RAW 264.7 Cells | 2 | 2019 | 316 | 0.22 | Why? |
| Disease Progression | 3 | 2020 | 13580 | 0.22 | Why? |
| Zebrafish | 2 | 2018 | 181 | 0.22 | Why? |
| Visual Acuity | 2 | 2018 | 790 | 0.22 | Why? |
| Cell Adhesion | 2 | 2018 | 230 | 0.22 | Why? |
| T-Lymphocytes | 1 | 2018 | 6670 | 0.21 | Why? |
| Gene Expression Regulation | 3 | 2019 | 4020 | 0.21 | Why? |
| Drug Synergism | 3 | 2019 | 833 | 0.21 | Why? |
| Lethal Dose 50 | 1 | 2019 | 63 | 0.21 | Why? |
| Chemical and Drug Induced Liver Injury | 2 | 2018 | 451 | 0.21 | Why? |
| Tumor Escape | 1 | 2019 | 36 | 0.20 | Why? |
| Genetic Linkage | 2 | 2017 | 87 | 0.20 | Why? |
| Cells, Cultured | 5 | 2018 | 5835 | 0.20 | Why? |
| Spinal Cord | 2 | 2018 | 281 | 0.20 | Why? |
| Amphibian Venoms | 1 | 2019 | 2 | 0.20 | Why? |
| NG-Nitroarginine Methyl Ester | 1 | 2019 | 6 | 0.20 | Why? |
| Epiretinal Membrane | 1 | 2019 | 9 | 0.20 | Why? |
| Zinc Finger Protein GLI1 | 1 | 2018 | 5 | 0.20 | Why? |
| Dextran Sulfate | 1 | 2019 | 54 | 0.20 | Why? |
| Nasopharyngeal Neoplasms | 2 | 2017 | 64 | 0.20 | Why? |
| Pedigree | 2 | 2018 | 502 | 0.20 | Why? |
| Germination | 1 | 2018 | 8 | 0.19 | Why? |
| Morphine Derivatives | 1 | 2018 | 3 | 0.19 | Why? |
| Proto-Oncogene Proteins c-fos | 1 | 2019 | 50 | 0.19 | Why? |
| Receptors, KIR2DL2 | 1 | 2018 | 4 | 0.19 | Why? |
| Carcinoma, Non-Small-Cell Lung | 3 | 2019 | 896 | 0.19 | Why? |
| Seedlings | 1 | 2018 | 13 | 0.19 | Why? |
| Middle Aged | 32 | 2020 | 270681 | 0.19 | Why? |
| Angiography | 2 | 2018 | 301 | 0.19 | Why? |
| Rhizosphere | 1 | 2018 | 8 | 0.19 | Why? |
| Uterus | 1 | 2019 | 98 | 0.19 | Why? |
| Porphyromonas gingivalis | 1 | 2018 | 19 | 0.19 | Why? |
| Chromones | 1 | 2019 | 42 | 0.19 | Why? |
| Semen Analysis | 1 | 2020 | 235 | 0.19 | Why? |
| Vasodilator Agents | 1 | 2002 | 344 | 0.19 | Why? |
| Mice, Inbred BALB C | 4 | 2018 | 5814 | 0.19 | Why? |
| Diosgenin | 1 | 2018 | 8 | 0.19 | Why? |
| Mossy Fibers, Hippocampal | 1 | 2018 | 1 | 0.19 | Why? |
| Shaw Potassium Channels | 1 | 2018 | 2 | 0.19 | Why? |
| Bifidobacterium longum | 1 | 2018 | 23 | 0.19 | Why? |
| Glucuronosyltransferase | 1 | 2018 | 24 | 0.19 | Why? |
| Choroid Neoplasms | 1 | 2018 | 9 | 0.19 | Why? |
| Retinal Neovascularization | 1 | 2018 | 29 | 0.19 | Why? |
| Bacterial Adhesion | 1 | 2018 | 69 | 0.19 | Why? |
| Ophthalmoscopy | 1 | 2019 | 65 | 0.19 | Why? |
| Tetracycline | 1 | 2018 | 33 | 0.19 | Why? |
| Cell Nucleus | 2 | 2018 | 399 | 0.19 | Why? |
| Oligodendroglia | 1 | 2018 | 57 | 0.19 | Why? |
| Retinal Perforations | 1 | 2018 | 19 | 0.19 | Why? |
| Erlotinib Hydrochloride | 1 | 2018 | 48 | 0.19 | Why? |
| Cell Polarity | 1 | 2019 | 85 | 0.19 | Why? |
| Nephritis, Hereditary | 1 | 2018 | 6 | 0.19 | Why? |
| Podophyllin | 1 | 2017 | 1 | 0.19 | Why? |
| Retinal Drusen | 1 | 2018 | 7 | 0.19 | Why? |
| Acetylcholinesterase | 1 | 2018 | 62 | 0.19 | Why? |
| Nitric Oxide Synthase Type III | 1 | 2019 | 87 | 0.19 | Why? |
| Transfection | 2 | 2018 | 864 | 0.18 | Why? |
| Nitric Oxide Synthase Type II | 1 | 2018 | 119 | 0.18 | Why? |
| Cholinesterase Inhibitors | 1 | 2019 | 99 | 0.18 | Why? |
| Central Serous Chorioretinopathy | 1 | 2018 | 20 | 0.18 | Why? |
| Retinal Vein | 1 | 2018 | 16 | 0.18 | Why? |
| Aspartic Acid Endopeptidases | 1 | 2018 | 57 | 0.18 | Why? |
| Models, Biological | 5 | 2018 | 4907 | 0.18 | Why? |
| Nevus | 1 | 2018 | 42 | 0.18 | Why? |
| Animals, Genetically Modified | 1 | 2018 | 230 | 0.18 | Why? |
| Stiff-Person Syndrome | 1 | 2017 | 2 | 0.18 | Why? |
| Catalase | 1 | 2018 | 97 | 0.18 | Why? |
| Amyloid Precursor Protein Secretases | 1 | 2018 | 38 | 0.18 | Why? |
| Receptors, Glycine | 1 | 2017 | 10 | 0.18 | Why? |
| Nanotubes | 1 | 2018 | 72 | 0.18 | Why? |
| Plant Roots | 1 | 2018 | 108 | 0.18 | Why? |
| Promoter Regions, Genetic | 6 | 2017 | 823 | 0.18 | Why? |
| Transcription Factor RelA | 1 | 2018 | 122 | 0.18 | Why? |
| RNA, Small Interfering | 6 | 2018 | 817 | 0.18 | Why? |
| Mitogen-Activated Protein Kinase 1 | 1 | 2017 | 43 | 0.18 | Why? |
| Gas Chromatography-Mass Spectrometry | 1 | 2018 | 187 | 0.18 | Why? |
| Mitogen-Activated Protein Kinase 3 | 1 | 2017 | 44 | 0.18 | Why? |
| RNA, Neoplasm | 1 | 2017 | 34 | 0.18 | Why? |
| Adipogenesis | 1 | 2017 | 38 | 0.18 | Why? |
| Chromatography, Gel | 1 | 2017 | 71 | 0.18 | Why? |
| Crystallography | 1 | 2017 | 52 | 0.18 | Why? |
| Scattering, Small Angle | 1 | 2017 | 91 | 0.18 | Why? |
| Anesthesia Recovery Period | 1 | 2017 | 18 | 0.17 | Why? |
| Jumonji Domain-Containing Histone Demethylases | 1 | 2017 | 28 | 0.17 | Why? |
| Protein Domains | 4 | 2019 | 6563 | 0.17 | Why? |
| Circular Dichroism | 1 | 2017 | 154 | 0.17 | Why? |
| Gene Knockout Techniques | 1 | 2018 | 347 | 0.17 | Why? |
| Homeodomain Proteins | 1 | 2018 | 93 | 0.17 | Why? |
| Phenylthiohydantoin | 1 | 2018 | 87 | 0.17 | Why? |
| China | 15 | 2020 | 50654 | 0.17 | Why? |
| Forkhead Transcription Factors | 1 | 2019 | 231 | 0.17 | Why? |
| Cerebral Amyloid Angiopathy | 1 | 2017 | 30 | 0.17 | Why? |
| Heart Septal Defects, Atrial | 1 | 2018 | 61 | 0.17 | Why? |
| p38 Mitogen-Activated Protein Kinases | 1 | 2019 | 230 | 0.17 | Why? |
| Salmonella typhimurium | 1 | 2017 | 81 | 0.17 | Why? |
| Peroxidase | 1 | 2018 | 207 | 0.17 | Why? |
| Synapses | 1 | 2017 | 83 | 0.17 | Why? |
| Gonadal Steroid Hormones | 1 | 2020 | 328 | 0.17 | Why? |
| Glutathione | 1 | 2019 | 280 | 0.17 | Why? |
| Spleen | 2 | 2018 | 877 | 0.17 | Why? |
| Spectrometry, Mass, Electrospray Ionization | 1 | 2018 | 159 | 0.17 | Why? |
| Fullerenes | 1 | 2017 | 30 | 0.17 | Why? |
| Emodin | 1 | 2017 | 32 | 0.17 | Why? |
| Cytoplasm | 1 | 2018 | 304 | 0.17 | Why? |
| S100 Calcium Binding Protein beta Subunit | 1 | 2017 | 63 | 0.17 | Why? |
| Exons | 1 | 2017 | 158 | 0.17 | Why? |
| Thermodynamics | 2 | 2019 | 873 | 0.17 | Why? |
| Regional Blood Flow | 1 | 2018 | 172 | 0.17 | Why? |
| Spectrometry, Fluorescence | 1 | 2017 | 177 | 0.16 | Why? |
| X-Ray Diffraction | 1 | 2017 | 249 | 0.16 | Why? |
| Toll-Like Receptor 9 | 1 | 2017 | 72 | 0.16 | Why? |
| Pneumonia, Viral | 11 | 2020 | 243684 | 0.16 | Why? |
| STAT1 Transcription Factor | 1 | 2019 | 313 | 0.16 | Why? |
| HIV Protease Inhibitors | 1 | 2020 | 434 | 0.16 | Why? |
| THP-1 Cells | 1 | 2018 | 374 | 0.16 | Why? |
| Enterocolitis, Necrotizing | 1 | 2017 | 71 | 0.16 | Why? |
| Morpholines | 1 | 2019 | 351 | 0.16 | Why? |
| Protein Kinase Inhibitors | 4 | 2019 | 1585 | 0.16 | Why? |
| Osteogenesis | 1 | 2017 | 95 | 0.16 | Why? |
| Coronavirus Infections | 11 | 2020 | 253789 | 0.16 | Why? |
| TOR Serine-Threonine Kinases | 1 | 2019 | 385 | 0.16 | Why? |
| Titanium | 1 | 2018 | 175 | 0.16 | Why? |
| Luciferases | 1 | 2018 | 378 | 0.16 | Why? |
| Aged | 23 | 2020 | 215776 | 0.16 | Why? |
| Phosphatidylinositol 3-Kinases | 1 | 2019 | 347 | 0.16 | Why? |
| Concanavalin A | 2 | 2018 | 19 | 0.16 | Why? |
| Clinical Laboratory Techniques | 2 | 2020 | 23402 | 0.16 | Why? |
| Clinical Chemistry Tests | 1 | 2017 | 82 | 0.16 | Why? |
| Biocompatible Materials | 1 | 2018 | 214 | 0.16 | Why? |
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 2017 | 102 | 0.16 | Why? |
| Carcinoma | 2 | 2017 | 256 | 0.16 | Why? |
| Blood Flow Velocity | 1 | 2017 | 193 | 0.16 | Why? |
| Tissue Distribution | 1 | 2018 | 483 | 0.16 | Why? |
| Demyelinating Diseases | 1 | 2018 | 224 | 0.15 | Why? |
| Astrocytes | 1 | 2018 | 298 | 0.15 | Why? |
| Protein Engineering | 1 | 2019 | 536 | 0.15 | Why? |
| Antineoplastic Agents, Phytogenic | 1 | 2017 | 183 | 0.15 | Why? |
| Retinal Vein Occlusion | 1 | 2018 | 129 | 0.15 | Why? |
| Amyloid beta-Peptides | 1 | 2017 | 185 | 0.15 | Why? |
| Epithelial-Mesenchymal Transition | 1 | 2018 | 242 | 0.15 | Why? |
| Toll-Like Receptor 4 | 2 | 2017 | 390 | 0.15 | Why? |
| Retinal Detachment | 1 | 2018 | 146 | 0.15 | Why? |
| Radio Waves | 1 | 2015 | 27 | 0.15 | Why? |
| Cell Differentiation | 2 | 2018 | 1338 | 0.15 | Why? |
| Mutation, Missense | 2 | 2018 | 863 | 0.15 | Why? |
| Mucin-1 | 1 | 2018 | 277 | 0.15 | Why? |
| Plasmids | 1 | 2018 | 840 | 0.14 | Why? |
| Neuroprotective Agents | 1 | 2018 | 240 | 0.14 | Why? |
| Dose-Response Relationship, Drug | 3 | 2019 | 3776 | 0.14 | Why? |
| Early Growth Response Protein 1 | 1 | 2014 | 12 | 0.14 | Why? |
| Immunoglobulins | 1 | 2020 | 811 | 0.14 | Why? |
| Microglia | 1 | 2018 | 357 | 0.14 | Why? |
| Dopamine | 3 | 2018 | 123 | 0.14 | Why? |
| Neoplasm Metastasis | 1 | 2018 | 682 | 0.14 | Why? |
| DNA Mutational Analysis | 1 | 2017 | 581 | 0.14 | Why? |
| CD11b Antigen | 1 | 2014 | 90 | 0.14 | Why? |
| Transcription Factor AP-2 | 1 | 2013 | 9 | 0.14 | Why? |
| Reconstructive Surgical Procedures | 1 | 2004 | 860 | 0.14 | Why? |
| Lymph Nodes | 2 | 2018 | 1060 | 0.14 | Why? |
| Statistics as Topic | 1 | 2017 | 370 | 0.14 | Why? |
| Th2 Cells | 1 | 2018 | 680 | 0.14 | Why? |
| Semen | 1 | 2020 | 550 | 0.14 | Why? |
| Isoenzymes | 1 | 2014 | 127 | 0.14 | Why? |
| Automation | 1 | 2017 | 429 | 0.14 | Why? |
| Biofilms | 1 | 2017 | 304 | 0.14 | Why? |
| Chromatography, Liquid | 1 | 2018 | 640 | 0.14 | Why? |
| T-Lymphocytes, Cytotoxic | 1 | 2018 | 552 | 0.14 | Why? |
| RNA, Messenger | 2 | 2018 | 5131 | 0.13 | Why? |
| Protein Processing, Post-Translational | 1 | 2017 | 634 | 0.13 | Why? |
| Interleukin-17 | 1 | 2019 | 602 | 0.13 | Why? |
| Microvessels | 1 | 2018 | 490 | 0.13 | Why? |
| RNA Interference | 4 | 2018 | 534 | 0.13 | Why? |
| Administration, Inhalation | 1 | 2020 | 1647 | 0.13 | Why? |
| Blood-Brain Barrier | 1 | 2018 | 531 | 0.13 | Why? |
| Cholestasis | 1 | 2015 | 114 | 0.13 | Why? |
| Polyethylene Glycols | 1 | 2018 | 574 | 0.13 | Why? |
| Crystallography, X-Ray | 2 | 2019 | 2689 | 0.13 | Why? |
| Cholesterol | 1 | 2018 | 660 | 0.13 | Why? |
| Lipopolysaccharides | 1 | 2018 | 848 | 0.13 | Why? |
| Computational Biology | 2 | 2019 | 4514 | 0.13 | Why? |
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2017 | 449 | 0.12 | Why? |
| Microcirculation | 1 | 2017 | 447 | 0.12 | Why? |
| Disease-Free Survival | 1 | 2018 | 1654 | 0.12 | Why? |
| Staphylococcus aureus | 1 | 2019 | 844 | 0.12 | Why? |
| Pharynx | 1 | 2020 | 1544 | 0.12 | Why? |
| Amino Acids | 1 | 2017 | 552 | 0.12 | Why? |
| Central Nervous System | 1 | 2018 | 701 | 0.12 | Why? |
| RNA, Viral | 1 | 2020 | 32276 | 0.12 | Why? |
| Immunoglobulin M | 2 | 2020 | 9091 | 0.12 | Why? |
| Antineoplastic Agents | 2 | 2019 | 3550 | 0.12 | Why? |
| Cell Separation | 1 | 2014 | 270 | 0.12 | Why? |
| Aged, 80 and over | 13 | 2020 | 88759 | 0.12 | Why? |
| Carcinoma, Renal Cell | 1 | 2019 | 545 | 0.12 | Why? |
| Betacoronavirus | 9 | 2020 | 204454 | 0.12 | Why? |
| Aging | 2 | 2020 | 3581 | 0.12 | Why? |
| Cell Membrane | 1 | 2017 | 743 | 0.12 | Why? |
| Substrate Specificity | 1 | 2014 | 639 | 0.12 | Why? |
| Bile Duct Neoplasms | 1 | 2015 | 172 | 0.12 | Why? |
| Myocytes, Cardiac | 1 | 2018 | 804 | 0.12 | Why? |
| Molecular Dynamics Simulation | 3 | 2020 | 4155 | 0.12 | Why? |
| Retinal Diseases | 1 | 2017 | 441 | 0.12 | Why? |
| Tandem Mass Spectrometry | 1 | 2018 | 1031 | 0.11 | Why? |
| Protective Factors | 1 | 2018 | 1720 | 0.11 | Why? |
| NF-kappa B | 1 | 2019 | 1301 | 0.11 | Why? |
| Structure-Activity Relationship | 4 | 2019 | 2219 | 0.11 | Why? |
| Ribavirin | 1 | 2018 | 1182 | 0.11 | Why? |
| Antibodies, Viral | 2 | 2020 | 51949 | 0.11 | Why? |
| Lung | 3 | 2020 | 31049 | 0.11 | Why? |
| Kidney Neoplasms | 1 | 2019 | 832 | 0.11 | Why? |
| Adenocarcinoma | 1 | 2017 | 651 | 0.11 | Why? |
| Synaptic Transmission | 2 | 2017 | 46 | 0.11 | Why? |
| Epigenesis, Genetic | 1 | 2017 | 711 | 0.11 | Why? |
| Probiotics | 1 | 2018 | 694 | 0.10 | Why? |
| Lymphocyte Activation | 2 | 2018 | 2742 | 0.10 | Why? |
| Gene Expression | 2 | 2019 | 3332 | 0.10 | Why? |
| Seroconversion | 1 | 2020 | 2515 | 0.10 | Why? |
| Intestinal Mucosa | 1 | 2018 | 1046 | 0.10 | Why? |
| Proteolysis | 1 | 2014 | 751 | 0.10 | Why? |
| Case-Control Studies | 3 | 2018 | 17671 | 0.10 | Why? |
| Interferon-alpha | 1 | 2018 | 1442 | 0.10 | Why? |
| Adult | 19 | 2020 | 244371 | 0.10 | Why? |
| Anti-Inflammatory Agents | 2 | 2020 | 6153 | 0.10 | Why? |
| Pyrimidines | 1 | 2018 | 1557 | 0.10 | Why? |
| Regression Analysis | 1 | 2017 | 2484 | 0.10 | Why? |
| Treatment Outcome | 7 | 2020 | 51732 | 0.10 | Why? |
| Models, Molecular | 3 | 2019 | 7616 | 0.10 | Why? |
| Antipsychotic Agents | 1 | 2018 | 887 | 0.10 | Why? |
| Flow Cytometry | 2 | 2017 | 2393 | 0.10 | Why? |
| Diagnosis, Differential | 3 | 2018 | 7220 | 0.10 | Why? |
| Combined Modality Therapy | 1 | 2018 | 3395 | 0.10 | Why? |
| Drug Resistance, Multiple, Bacterial | 1 | 2017 | 1115 | 0.10 | Why? |
| T-Lymphocyte Subsets | 1 | 2017 | 1387 | 0.09 | Why? |
| Lopinavir | 2 | 2020 | 4308 | 0.09 | Why? |
| Immunoglobulin G | 4 | 2020 | 21571 | 0.09 | Why? |
| Cesarean Section | 1 | 2019 | 2089 | 0.09 | Why? |
| Kaplan-Meier Estimate | 1 | 2018 | 4260 | 0.09 | Why? |
| Hepatitis C, Chronic | 1 | 2018 | 973 | 0.09 | Why? |
| Random Allocation | 2 | 2017 | 773 | 0.09 | Why? |
| Sleep Apnea, Obstructive | 1 | 2017 | 668 | 0.09 | Why? |
| Ritonavir | 2 | 2020 | 4212 | 0.09 | Why? |
| Limit of Detection | 1 | 2017 | 2698 | 0.09 | Why? |
| Biocatalysis | 2 | 2018 | 100 | 0.09 | Why? |
| Receptors, Dopamine D2 | 2 | 2018 | 22 | 0.09 | Why? |
| Hydrolysis | 2 | 2018 | 160 | 0.09 | Why? |
| Immunohistochemistry | 3 | 2017 | 2275 | 0.09 | Why? |
| Alzheimer Disease | 1 | 2018 | 1020 | 0.09 | Why? |
| Prognosis | 4 | 2020 | 32490 | 0.09 | Why? |
| Schizophrenia | 1 | 2018 | 1018 | 0.09 | Why? |
| Reproducibility of Results | 4 | 2017 | 11304 | 0.09 | Why? |
| Catalysis | 2 | 2018 | 253 | 0.09 | Why? |
| Glucocorticoids | 2 | 2020 | 4431 | 0.09 | Why? |
| Child, Preschool | 4 | 2020 | 36283 | 0.09 | Why? |
| Nerve Fibers | 2 | 2018 | 73 | 0.09 | Why? |
| Transplantation, Heterologous | 2 | 2017 | 77 | 0.09 | Why? |
| Retinal Ganglion Cells | 2 | 2018 | 80 | 0.08 | Why? |
| Multiple Myeloma | 1 | 2017 | 1064 | 0.08 | Why? |
| Lupus Erythematosus, Systemic | 1 | 2018 | 1380 | 0.08 | Why? |
| Pyrazoles | 1 | 2018 | 1791 | 0.08 | Why? |
| Inflammation | 3 | 2020 | 13255 | 0.08 | Why? |
| A549 Cells | 3 | 2017 | 2066 | 0.08 | Why? |
| Drug Discovery | 2 | 2018 | 3092 | 0.08 | Why? |
| Cognitive Dysfunction | 1 | 2018 | 1389 | 0.08 | Why? |
| Drugs, Chinese Herbal | 2 | 2020 | 2760 | 0.08 | Why? |
| Gene Knockdown Techniques | 2 | 2018 | 347 | 0.08 | Why? |
| Antiviral Agents | 4 | 2020 | 41703 | 0.08 | Why? |
| Lymphocyte Count | 1 | 2018 | 4758 | 0.08 | Why? |
| Myocardium | 1 | 2018 | 2323 | 0.08 | Why? |
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2017 | 1573 | 0.08 | Why? |
| Pregnancy Complications | 1 | 2018 | 1388 | 0.08 | Why? |
| Blood Platelets | 1 | 2017 | 1704 | 0.08 | Why? |
| Protein Transport | 2 | 2018 | 487 | 0.08 | Why? |
| Implants, Experimental | 1 | 2004 | 6 | 0.08 | Why? |
| Mice, Transgenic | 3 | 2017 | 2739 | 0.07 | Why? |
| Uterine Prolapse | 1 | 2004 | 5 | 0.07 | Why? |
| Drug Evaluation, Preclinical | 1 | 2017 | 3347 | 0.07 | Why? |
| Polytetrafluoroethylene | 1 | 2004 | 19 | 0.07 | Why? |
| Pandemics | 13 | 2020 | 389249 | 0.07 | Why? |
| Equipment Design | 1 | 2016 | 3095 | 0.07 | Why? |
| Tensile Strength | 1 | 2004 | 42 | 0.07 | Why? |
| Prospective Studies | 7 | 2018 | 43301 | 0.07 | Why? |
| Adolescent | 7 | 2020 | 86841 | 0.07 | Why? |
| Young Adult | 8 | 2020 | 93724 | 0.07 | Why? |
| Prostatic Neoplasms | 1 | 2017 | 1637 | 0.07 | Why? |
| Tomography, X-Ray Computed | 3 | 2020 | 25144 | 0.07 | Why? |
| Autoimmune Diseases | 1 | 2018 | 1996 | 0.07 | Why? |
| Parkinson Disease | 1 | 2017 | 1414 | 0.07 | Why? |
| Liver | 2 | 2017 | 4007 | 0.07 | Why? |
| Immunotherapy | 1 | 2018 | 2421 | 0.07 | Why? |
| Protein Structure, Secondary | 2 | 2019 | 1077 | 0.07 | Why? |
| Computer Simulation | 1 | 2019 | 4982 | 0.07 | Why? |
| Thiazolidinediones | 2 | 2014 | 70 | 0.07 | Why? |
| Retrospective Studies | 6 | 2020 | 105322 | 0.07 | Why? |
| Prostheses and Implants | 1 | 2004 | 116 | 0.07 | Why? |
| Biopsy, Needle | 1 | 2004 | 303 | 0.07 | Why? |
| Sensitivity and Specificity | 2 | 2020 | 22971 | 0.07 | Why? |
| B-Lymphocytes | 1 | 2018 | 4418 | 0.06 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2020 | 13720 | 0.06 | Why? |
| Survival Rate | 1 | 2018 | 9206 | 0.06 | Why? |
| Adrenal Cortex Hormones | 1 | 2020 | 6537 | 0.06 | Why? |
| Patch-Clamp Techniques | 1 | 2002 | 49 | 0.06 | Why? |
| Nitriles | 2 | 2018 | 1053 | 0.06 | Why? |
| Acute Coronary Syndrome | 1 | 2017 | 2107 | 0.06 | Why? |
| Collagen | 1 | 2004 | 222 | 0.06 | Why? |
| Ultrasonography | 1 | 2019 | 4409 | 0.06 | Why? |
| Membrane Potentials | 1 | 2002 | 56 | 0.06 | Why? |
| Protein Multimerization | 2 | 2019 | 1336 | 0.06 | Why? |
| Evoked Potentials | 1 | 2002 | 44 | 0.06 | Why? |
| Rats, Wistar | 1 | 2004 | 621 | 0.06 | Why? |
| gamma-Aminobutyric Acid | 1 | 2002 | 52 | 0.06 | Why? |
| Brain Ischemia | 1 | 2018 | 2813 | 0.06 | Why? |
| Molecular Structure | 2 | 2018 | 1539 | 0.06 | Why? |
| Binding Sites | 3 | 2019 | 6201 | 0.06 | Why? |
| Materials Testing | 1 | 2004 | 380 | 0.06 | Why? |
| Follow-Up Studies | 2 | 2020 | 17020 | 0.06 | Why? |
| Introns | 1 | 2021 | 112 | 0.06 | Why? |
| Interleukins | 2 | 2018 | 762 | 0.06 | Why? |
| Healthy Volunteers | 2 | 2018 | 1444 | 0.06 | Why? |
| Machine Learning | 1 | 2018 | 4395 | 0.06 | Why? |
| Drug Repositioning | 1 | 2020 | 5683 | 0.06 | Why? |
| Statistics, Nonparametric | 1 | 2004 | 1008 | 0.06 | Why? |
| Surgical Procedures, Operative | 1 | 2017 | 2662 | 0.05 | Why? |
| Cyclooxygenase 1 | 1 | 2020 | 20 | 0.05 | Why? |
| Inflammatory Bowel Diseases | 1 | 2018 | 3209 | 0.05 | Why? |
| Cyclooxygenase Inhibitors | 1 | 2020 | 46 | 0.05 | Why? |
| gamma-Globulins | 1 | 2020 | 73 | 0.05 | Why? |
| Mutation | 2 | 2018 | 12376 | 0.05 | Why? |
| Infant | 2 | 2020 | 30274 | 0.05 | Why? |
| Chemical Warfare Agents | 1 | 2019 | 9 | 0.05 | Why? |
| Breast Neoplasms | 1 | 2018 | 3633 | 0.05 | Why? |
| Cell Survival | 2 | 2017 | 1581 | 0.05 | Why? |
| Receptors, Prostaglandin E, EP4 Subtype | 1 | 2019 | 5 | 0.05 | Why? |
| Cyclooxygenase 2 | 1 | 2020 | 129 | 0.05 | Why? |
| HEK293 Cells | 3 | 2018 | 8394 | 0.05 | Why? |
| Methicillin Resistance | 1 | 2019 | 77 | 0.05 | Why? |
| Enzyme Stability | 1 | 2019 | 72 | 0.05 | Why? |
| Kinetics | 2 | 2018 | 3238 | 0.05 | Why? |
| Organophosphorus Compounds | 1 | 2019 | 53 | 0.05 | Why? |
| Pregnancy | 2 | 2019 | 23879 | 0.05 | Why? |
| Activation, Metabolic | 1 | 2018 | 6 | 0.05 | Why? |
| GRB2 Adaptor Protein | 1 | 2018 | 5 | 0.05 | Why? |
| Immunological Synapses | 1 | 2018 | 6 | 0.05 | Why? |
| Photoelectron Spectroscopy | 1 | 2018 | 24 | 0.05 | Why? |
| Trinitrobenzenesulfonic Acid | 1 | 2018 | 12 | 0.05 | Why? |
| Receptors, Opioid | 1 | 2018 | 25 | 0.05 | Why? |
| Phenothiazines | 1 | 2018 | 50 | 0.05 | Why? |
| Zonula Occludens-1 Protein | 1 | 2018 | 54 | 0.05 | Why? |
| Dopamine Plasma Membrane Transport Proteins | 1 | 2018 | 37 | 0.05 | Why? |
| Analysis of Variance | 1 | 2002 | 950 | 0.05 | Why? |
| Age Factors | 1 | 2020 | 21039 | 0.05 | Why? |
| Gene Knock-In Techniques | 1 | 2018 | 124 | 0.05 | Why? |
| Virus Replication | 1 | 2020 | 14331 | 0.05 | Why? |
| Catechols | 1 | 2018 | 43 | 0.05 | Why? |
| Epigenetic Repression | 1 | 2017 | 5 | 0.05 | Why? |
| In Vitro Techniques | 1 | 2002 | 1027 | 0.05 | Why? |
| Streptolysins | 1 | 2017 | 8 | 0.05 | Why? |
| Mice, Inbred ICR | 1 | 2019 | 242 | 0.05 | Why? |
| Postoperative Complications | 1 | 2017 | 5861 | 0.05 | Why? |
| NF-kappa B p50 Subunit | 1 | 2018 | 64 | 0.04 | Why? |
| Mice, 129 Strain | 1 | 2017 | 36 | 0.04 | Why? |
| Homovanillic Acid | 1 | 2017 | 4 | 0.04 | Why? |
| Extracellular Fluid | 1 | 2017 | 19 | 0.04 | Why? |
| Mutant Proteins | 1 | 2019 | 328 | 0.04 | Why? |
| Ion Channel Gating | 1 | 2017 | 22 | 0.04 | Why? |
| G-Protein-Coupled Receptor Kinase 2 | 1 | 2017 | 9 | 0.04 | Why? |
| Tyrosine 3-Monooxygenase | 1 | 2017 | 32 | 0.04 | Why? |
| Protein Aggregation, Pathological | 1 | 2017 | 36 | 0.04 | Why? |
| Intestinal Atresia | 1 | 2017 | 2 | 0.04 | Why? |
| Succinimides | 1 | 2017 | 3 | 0.04 | Why? |
| Dimerization | 1 | 2019 | 475 | 0.04 | Why? |
| Fractals | 1 | 2017 | 25 | 0.04 | Why? |
| Complement C4 | 1 | 2017 | 86 | 0.04 | Why? |
| Heterozygote | 1 | 2018 | 249 | 0.04 | Why? |
| Motor Neurons | 1 | 2017 | 52 | 0.04 | Why? |
| Insecticides | 1 | 2019 | 178 | 0.04 | Why? |
| Feedback, Physiological | 1 | 2017 | 56 | 0.04 | Why? |
| Molecular Weight | 1 | 2017 | 249 | 0.04 | Why? |
| Permeability | 1 | 2018 | 238 | 0.04 | Why? |
| Intestine, Large | 1 | 2017 | 52 | 0.04 | Why? |
| Extracellular Signal-Regulated MAP Kinases | 1 | 2017 | 92 | 0.04 | Why? |
| Glycine | 1 | 2018 | 203 | 0.04 | Why? |
| Health Status Indicators | 1 | 2020 | 341 | 0.04 | Why? |
| Enzyme Activation | 1 | 2018 | 425 | 0.04 | Why? |
| Surface Properties | 1 | 2018 | 448 | 0.04 | Why? |
| Prostatic Neoplasms, Castration-Resistant | 1 | 2018 | 109 | 0.04 | Why? |
| Osteoblasts | 1 | 2017 | 87 | 0.04 | Why? |
| Berlin | 1 | 2017 | 283 | 0.04 | Why? |
| Levodopa | 1 | 2017 | 87 | 0.04 | Why? |
| Cell Cycle | 1 | 2017 | 329 | 0.04 | Why? |
| Methylation | 1 | 2017 | 332 | 0.04 | Why? |
| Cough | 2 | 2020 | 4891 | 0.04 | Why? |
| Dabigatran | 1 | 2018 | 204 | 0.04 | Why? |
| Inflammation Mediators | 2 | 2019 | 2654 | 0.04 | Why? |
| Electric Impedance | 1 | 2018 | 283 | 0.04 | Why? |
| Gene Silencing | 1 | 2017 | 213 | 0.04 | Why? |
| Inhibitory Concentration 50 | 1 | 2019 | 907 | 0.04 | Why? |
| Serum Amyloid A Protein | 1 | 2017 | 211 | 0.04 | Why? |
| Child | 3 | 2020 | 70012 | 0.04 | Why? |
| Support Vector Machine | 1 | 2018 | 330 | 0.04 | Why? |
| Arginine | 1 | 2018 | 377 | 0.04 | Why? |
| Publication Bias | 1 | 2017 | 241 | 0.04 | Why? |
| Indicators and Reagents | 1 | 2017 | 183 | 0.04 | Why? |
| Endoplasmic Reticulum Stress | 1 | 2018 | 253 | 0.04 | Why? |
| Drug Resistance, Neoplasm | 1 | 2019 | 447 | 0.04 | Why? |
| Swine | 1 | 2004 | 3352 | 0.04 | Why? |
| Plasma Cells | 1 | 2018 | 464 | 0.04 | Why? |
| Benzamides | 1 | 2018 | 421 | 0.04 | Why? |
| Complement C3 | 1 | 2017 | 271 | 0.04 | Why? |
| Genetic Association Studies | 1 | 2018 | 559 | 0.04 | Why? |
| Respiration, Artificial | 1 | 2020 | 22116 | 0.04 | Why? |
| Oxidation-Reduction | 1 | 2017 | 540 | 0.04 | Why? |
| Testosterone | 1 | 2020 | 596 | 0.03 | Why? |
| Caco-2 Cells | 1 | 2018 | 1236 | 0.03 | Why? |
| Narcotic Antagonists | 1 | 2018 | 317 | 0.03 | Why? |
| Immunoglobulin E | 1 | 2017 | 557 | 0.03 | Why? |
| Drug Therapy, Combination | 2 | 2018 | 7268 | 0.03 | Why? |
| Oseltamivir | 1 | 2018 | 583 | 0.03 | Why? |
| Graft Rejection | 1 | 2004 | 1766 | 0.03 | Why? |
| Nomograms | 1 | 2020 | 790 | 0.03 | Why? |
| Intestine, Small | 1 | 2017 | 336 | 0.03 | Why? |
| Interferon-gamma | 2 | 2017 | 2711 | 0.03 | Why? |
| Protein Structure, Tertiary | 1 | 2018 | 1565 | 0.03 | Why? |
| Hepatocytes | 1 | 2017 | 549 | 0.03 | Why? |
| Gene Frequency | 1 | 2018 | 1210 | 0.03 | Why? |
| Multimodal Imaging | 1 | 2018 | 534 | 0.03 | Why? |
| Fever | 2 | 2020 | 7795 | 0.03 | Why? |
| Colon | 1 | 2018 | 669 | 0.03 | Why? |
| Area Under Curve | 1 | 2020 | 2564 | 0.03 | Why? |
| Clinical Trials, Phase III as Topic | 1 | 2017 | 782 | 0.03 | Why? |
| Vaccination | 1 | 2018 | 19050 | 0.03 | Why? |
| Flavonoids | 1 | 2017 | 492 | 0.03 | Why? |
| Catalytic Domain | 1 | 2019 | 1757 | 0.03 | Why? |
| Luminescent Measurements | 1 | 2017 | 924 | 0.03 | Why? |
| Antineoplastic Agents, Immunological | 1 | 2019 | 830 | 0.03 | Why? |
| Indoles | 1 | 2020 | 1243 | 0.03 | Why? |
| Syndrome | 1 | 2017 | 1310 | 0.03 | Why? |
| Escherichia coli | 1 | 2019 | 1547 | 0.03 | Why? |
| Transcription, Genetic | 1 | 2017 | 1326 | 0.03 | Why? |
| Amino Acid Substitution | 1 | 2018 | 1706 | 0.03 | Why? |
| Extracellular Space | 1 | 2010 | 26 | 0.03 | Why? |
| Drug Interactions | 1 | 2018 | 1653 | 0.03 | Why? |
| Autoimmunity | 1 | 2018 | 841 | 0.03 | Why? |
| Real-Time Polymerase Chain Reaction | 2 | 2020 | 11367 | 0.03 | Why? |
| Severity of Illness Index | 4 | 2020 | 48226 | 0.03 | Why? |
| Cricetinae | 1 | 2018 | 3344 | 0.03 | Why? |
| Liver Function Tests | 1 | 2017 | 1325 | 0.03 | Why? |
| Drug Combinations | 1 | 2020 | 3852 | 0.03 | Why? |
| Cross-Sectional Studies | 1 | 2018 | 53120 | 0.03 | Why? |
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2020 | 1454 | 0.03 | Why? |
| Staphylococcal Infections | 1 | 2019 | 1099 | 0.03 | Why? |
| Antibodies, Blocking | 1 | 2010 | 174 | 0.02 | Why? |
| Sex Distribution | 1 | 2017 | 2083 | 0.02 | Why? |
| Risk Factors | 4 | 2020 | 71621 | 0.02 | Why? |
| Polymerase Chain Reaction | 2 | 2017 | 6740 | 0.02 | Why? |
| Hepacivirus | 1 | 2018 | 1509 | 0.02 | Why? |
| Natural Killer T-Cells | 1 | 2010 | 191 | 0.02 | Why? |
| Anti-Infective Agents | 1 | 2019 | 1766 | 0.02 | Why? |
| Haplotypes | 1 | 2011 | 853 | 0.02 | Why? |
| Age Distribution | 1 | 2017 | 3567 | 0.02 | Why? |
| Autoantibodies | 1 | 2018 | 2094 | 0.02 | Why? |
| Time Factors | 2 | 2020 | 31397 | 0.02 | Why? |
| DNA Primers | 1 | 2011 | 1170 | 0.02 | Why? |
| Oxygen | 1 | 2020 | 3715 | 0.02 | Why? |
| Survival Analysis | 1 | 2020 | 7592 | 0.02 | Why? |
| Medicine, Chinese Traditional | 1 | 2019 | 2255 | 0.02 | Why? |
| Amino Acid Sequence | 1 | 2018 | 6049 | 0.02 | Why? |
| Immunoglobulin A | 1 | 2017 | 3567 | 0.02 | Why? |
| Bacteria | 1 | 2017 | 1897 | 0.02 | Why? |
| Biomarkers | 2 | 2020 | 23361 | 0.02 | Why? |
| Alleles | 1 | 2011 | 1557 | 0.02 | Why? |
| Chloroquine | 1 | 2020 | 3152 | 0.02 | Why? |
| Hospitalization | 3 | 2020 | 54280 | 0.02 | Why? |
| Feces | 1 | 2018 | 4235 | 0.02 | Why? |
| Risk Assessment | 2 | 2020 | 25439 | 0.02 | Why? |
| Body Mass Index | 1 | 2017 | 4306 | 0.02 | Why? |
| Virus Shedding | 1 | 2020 | 5834 | 0.02 | Why? |
| Immunologic Factors | 1 | 2020 | 4206 | 0.02 | Why? |
| Immunization, Passive | 1 | 2020 | 10067 | 0.02 | Why? |
| Thrombocytopenia | 1 | 2017 | 2093 | 0.02 | Why? |
| Molecular Docking Simulation | 1 | 2019 | 6902 | 0.02 | Why? |
| Protein Binding | 1 | 2019 | 11430 | 0.02 | Why? |
| Sex Factors | 1 | 2020 | 11014 | 0.02 | Why? |
| Logistic Models | 1 | 2017 | 9089 | 0.01 | Why? |
| Cell Line | 1 | 2017 | 12040 | 0.01 | Why? |
| C-Reactive Protein | 1 | 2017 | 7972 | 0.01 | Why? |
| Hypoglycemic Agents | 1 | 2013 | 2165 | 0.01 | Why? |
| Magnetic Resonance Imaging | 1 | 2017 | 6551 | 0.01 | Why? |
| Sepsis | 1 | 2017 | 3517 | 0.01 | Why? |
| Immunity, Innate | 1 | 2018 | 6570 | 0.01 | Why? |
| Interleukin-6 | 1 | 2017 | 7522 | 0.01 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2017 | 10649 | 0.01 | Why? |
| Anti-Bacterial Agents | 1 | 2018 | 10083 | 0.01 | Why? |
| Infant, Newborn | 1 | 2017 | 23105 | 0.01 | Why? |
| Intensive Care Units | 1 | 2020 | 29594 | 0.01 | Why? |
| Surveys and Questionnaires | 1 | 2017 | 43792 | 0.01 | Why? |